Tag: Enfortumab vedotin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Enfortumab vedotin

Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod

Added to Collection on: 2021-03-08 13:53:23

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Breakthrough therapy
Orphan drugs
Cancer immunotherapy
Antineoplastic drugs
Monoclonal antibodies
Atezolizumab
Pembrolizumab
PD-1 and PD-L1 inhibitors
Enfortumab vedotin

Click the tags to see associated articles and topics

View Article Details
Astellas Submits New Drug Application for Enfortumab Vedotin in Japan

Added to Collection on: 2021-03-11 06:56:15

Tags for this article:

Cancer treatments
Clinical medicine
Medicine
Breakthrough therapy
Cancer immunotherapy
Monoclonal antibodies
Antibody-drug conjugates
Antineoplastic drugs
Enfortumab vedotin
Seagen
Antibody-drug conjugate
Astellas Pharma
Cisplatin
Astellas Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Discoveries & Impact (March 2021)

Added to Collection on: 2021-03-11 18:55:33

Tags for this article:

Breakthrough therapy
Cancer immunotherapy
Enfortumab vedotin
Clinical medicine
Medicine

Click the tags to see associated articles and topics

View Article Details
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin

Added to Collection on: 2021-03-26 06:00:00

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Breakthrough therapy
Antineoplastic drugs
Monoclonal antibodies
Cancer immunotherapy
Antibody-drug conjugates
Enfortumab vedotin
Seagen
Transitional cell carcinoma
Antibody-drug conjugate
vedotin
Seagen Inc.
Astellas Pharma Inc.

Click the tags to see associated articles and topics

View Article Details
Xtandi raise, Padcev lift and a women's health surprise: Astellas outlines $17B 5-year plan

Added to Collection on: 2021-05-26 15:56:15

Tags for this article:

Chemical compounds
Cancer treatments
Life Sciences
Astellas Pharma
Mitsubishi UFJ Financial Group
Enzalutamide
Seagen
Pfizer
Gilteritinib
Antibody-drug conjugate
Enfortumab vedotin
Stephen Barker
Astellas

Click the tags to see associated articles and topics

View Article Details
Seagen (SGEN) Enters Exclusive Worldwide Licensing Agreement with RemGen to Develop ...

Added to Collection on: 2021-08-09 14:59:11

Tags for this article:

Life Sciences
Clinical medicine
Cancer treatments
Antibody-drug conjugates
Monoclonal antibodies
Breakthrough therapy
Antineoplastic drugs
Biotechnology
Seagen
Antibody-drug conjugate
Brentuximab vedotin
Enfortumab vedotin
RemeGen Co. Ltd.
Seagen Inc.

Click the tags to see associated articles and topics

View Article Details
Seagen to Highlight Preclinical Data for Enfortumab Vedotin and Two Novel Antibody-Drug ...

Added to Collection on: 2022-04-10 04:34:24

Tags for this article:

Cancer treatments
Clinical medicine
Medicine
Antineoplastic drugs
Antibody-drug conjugates
Monoclonal antibodies
Seagen
Biotechnology
Breakthrough therapy
Antibody-drug conjugate
Monomethyl auristatin E
Enfortumab vedotin
vedotin
SGN

Click the tags to see associated articles and topics

View Article Details
Astellas to Share New Data Across Hard-to-Treat Cancers During ESMO Congress 2023

Added to Collection on: 2023-10-15 23:09:11

Tags for this article:

Breakthrough therapy
Cancer immunotherapy
Antineoplastic drugs
Orphan drugs
Astellas Pharma
Mitsubishi UFJ Financial Group
Seagen
Enzalutamide
Pembrolizumab
Medivation
Enfortumab vedotin
Zolbetuximab
Astellas Pharma Inc.
United States

Click the tags to see associated articles and topics

View Article Details
Two Studies Show Improved Survival With Novel Front-Line Combinations in Advanced ...

Added to Collection on: 2023-11-16 21:42:48

Tags for this article:

Antineoplastic drugs
Breakthrough therapy
Cancer immunotherapy
Orphan drugs
Nivolumab
Pembrolizumab
Bladder cancer
Transitional cell carcinoma
Enfortumab vedotin
Seagen
Checkpoint inhibitor
Chemotherapy
Thomas Powles
Gemcitabine
Michiel van der Heijden
Cisplatin

Click the tags to see associated articles and topics

View Article Details
Pfizer and Astellas seek updated EMA approval for Padcev with Keytruda

Added to Collection on: 2024-01-29 16:46:26

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cancer immunotherapy
Pembrolizumab
Seagen
Antibody-drug conjugate
Astellas Pharma
Transitional cell carcinoma
Bladder cancer
Pfizer
Chemotherapy
Enfortumab vedotin

Click the tags to see associated articles and topics

View Article Details